DIMA Trademark

Trademark Overview


On Tuesday, December 2, 2025, a trademark application was filed for DIMA with the United States Patent and Trademark Office. The USPTO has given the DIMA trademark a serial number of 99525706. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 2, 2025. This trademark is owned by DIMA Biotechnology LTD. The DIMA trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Reagents for therapeutic, diagnostic and scientific research, namely, recombinant proteins and conjugates of recombinant proteins, monoclonal antibodies and conjugates of monoclonal antibodies; assay reagents and ELISA kits for biomedical research; Genetically engineered complementary DNA (cDNA); Engineered stable cell lines; Chemicals for protein extraction and purification; IgG antibodies from immunized animals and humans; Biological preparations for the treatment of multiple myeloma, blood tumor and solid tumor; Synthesized DNAs; Synthesized peptides

Scientific, technological and medical research services, namely, services for protein expression, protein and antibody engineering, protein and antibody chemical conjugation, monoclonal and polyclonal antibody development, cell line development, assay development, In Vivo animal study, In Vitro cell based assays, gene cloning, and genome editing
dima

General Information


Serial Number99525706
Word MarkDIMA
Filing DateTuesday, December 2, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, December 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesReagents for therapeutic, diagnostic and scientific research, namely, recombinant proteins and conjugates of recombinant proteins, monoclonal antibodies and conjugates of monoclonal antibodies; assay reagents and ELISA kits for biomedical research; Genetically engineered complementary DNA (cDNA); Engineered stable cell lines; Chemicals for protein extraction and purification; IgG antibodies from immunized animals and humans; Biological preparations for the treatment of multiple myeloma, blood tumor and solid tumor; Synthesized DNAs; Synthesized peptides
Goods and ServicesScientific, technological and medical research services, namely, services for protein expression, protein and antibody engineering, protein and antibody chemical conjugation, monoclonal and polyclonal antibody development, cell line development, assay development, In Vivo animal study, In Vitro cell based assays, gene cloning, and genome editing

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 2, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 2, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDIMA Biotechnology LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWuhan, Hubei Province 430070
CN

Trademark Events


Event DateEvent Description
Tuesday, December 2, 2025NEW APPLICATION ENTERED
Tuesday, December 2, 2025APPLICATION FILING RECEIPT MAILED